Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Melrose rises as it sees pick-up in some markets* BoE Deputy Governor Ramsden hints of more stimulus* FTSE 100 down 1.6%, FTSE 250 down 1.3% (Recasts throughout, adds comment...
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* European tech stocks mark worst day in over 4 months* Germany's Hellofresh bottoms out STOXX 600* French stocks fall despite 100 bln euro stimulus plan (Updates to market clo...
Read more* European shares open higher* STOXX 600 up 1.2% Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Ju...
Read more
(Sharecast News) - Sanofi and GSK said they had started a Phase 1/2 clinical trial for Covid-19 vaccine involving 440 people in the US.
Read more* Phase 1/2 trial enrols 440 adults in the U.S.* Final testing stage expected to start in December (Recasts with detail, context)By Sudip Kar-GuptaPARIS, Sept 3 (Reuters) - French drugmaker Sanofi and Britain's GlaxoSmithKline said they had started...
Read more
Sanofi And Glaxo Aim For December Start For Phase 3 Of Vaccine Trial
Read more(Sharecast News) - The US government said overnight that it will not participate in a global initiative to develop, manufacture and equitably distribute a vaccine for Covid-19 due to the World Health Organization's involvement.
Read moreIN BRIEF: GlaxoSmithKline And Vir Dose First Patient In Covid-19 Trial
Read moreAug 31 (Reuters) - GlaxoSmithKline and partner Vir Biotechnology have started testing their experimental antibody on early-stage COVID-19 patients, entering the race to find a winner in a promising class of antiviral drugs to combat the pandemic....
Read moreLONDON, Aug 28 (Reuters) - Britain's medical regulator will be able to grant temporary authorisation for any coronavirus vaccine that meets safety and quality standards but before it has received a full licence, under new plans set out on Friday.T...
Read moreGlaxoSmithKline Reports Positive Data From Hepatitis B Drug Trial
Read moreEuropean Regulator Approves Glaxo's Blood Cancer Treatment Blenrep
Read more(Sharecast News) - Moderna shares found a bid in the middle of the week after the biotechnology outfit announced that its experimental Covid-19 vaccine did generate antibodies against the disease in elderly patients.
Read more* EU ready to indemnify 'certain liabilities' -EU official* In securing shots, EU lags U.S. full shield* EU has so far reached vaccine deal only with AstraZeneca (Adds comment from EU vaccine lobby)By Francesco GuarascioBRUSSELS, Aug 26 (Reuters) - ...
Read more* EU ready to indemnify 'certain liabilities' - EU official* In securing shots, EU lags U.S. which offers full shield* EU has so far reached vaccine deal only with AstraZenecaBy Francesco GuarascioBRUSSELS, Aug 26 (Reuters) - The European Union is of...
Read more
Last checked at